{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T15:34:54Z","timestamp":1759073694781,"version":"3.37.3"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/0122","PI13\/00812","PI10\/02430"],"award-info":[{"award-number":["PI16\/0122","PI13\/00812","PI10\/02430"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003176","name":"Ministerio de Educaci\u00f3n, Cultura y Deporte","doi-asserted-by":"publisher","award":["FPU14\/06834"],"award-info":[{"award-number":["FPU14\/06834"]}],"id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00213-020-05526-8","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T09:03:12Z","timestamp":1588842192000},"page":"2151-2159","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identifying key transcription factors for pharmacogenetic studies of antipsychotics induced extrapyramidal symptoms"],"prefix":"10.1007","volume":"237","author":[{"given":"Daniel","family":"Boloc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Garc\u00eda-Cerro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Parellada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeronimo","family":"Saiz-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel J.","family":"Cuesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miquel","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Gass\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia","family":"Lafuente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergi","family":"Mas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan Albert","family":"Arnaiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,7]]},"reference":[{"key":"5526_CR1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.biopsych.2009.08.036","volume":"67","author":"K Aberg","year":"2010","unstructured":"Aberg K, Adkins DE, Buksz\u00e1r J, Webb BT, Caroff SN, Miller DD et al (2010) Genome wide association study of movement-related adverse antipsychotic effects. Biol Psychiatry 67:279\u2013282","journal-title":"Biol Psychiatry"},{"key":"5526_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hup.997","volume":"24","author":"AF Al Hadithy","year":"2009","unstructured":"Al Hadithy AF, Wilffert B, Bruggeman R, Stewart RE, Brouwers JR, Matroos GE et al (2009) Lack of association between antipsychotic-induced parkinsonism or its subsymptoms and rs4606 SNP of RGS2 gene in African-Caribbeans and the possible role of the medication: the Curacao extrapyramidal syndromes study X. Hum Psychopharmacol 24:123\u2013128","journal-title":"Hum Psychopharmacol"},{"key":"5526_CR3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00213-009-1627-z","volume":"206","author":"A Alkelai","year":"2009","unstructured":"Alkelai A, Greenbaum L, Rigbi A, Kanyas K, Lerer B (2009) Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients. Psychopharmacology 206:491\u2013499","journal-title":"Psychopharmacology"},{"key":"5526_CR4","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.celrep.2015.04.016","volume":"11","author":"KI Ansari","year":"2015","unstructured":"Ansari KI, Ogawa D, Rooj AK, Lawler SE, Krichevsky AM, Johnson MD, Chiocca EA, Bronisz A, Godlewski J (2015) Glucose-based regulation of miR-451\/AMPK signaling depends on the OCT1 transcription factor. Cell Rep 11:902\u2013909","journal-title":"Cell Rep"},{"key":"5526_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.rpsm.2012.11.001","volume":"6","author":"M Bernardo","year":"2013","unstructured":"Bernardo M, Bioque M, Parellada M, Saiz Ruiz J, Cuesta MJ, Llerena A, Sanju\u00e1n J, Castro-Fornieles J, Arango C, Cabrera B, PEPs Group (2013) Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs). Rev Psiquiatr Salud Ment 6:4\u201316","journal-title":"Rev Psiquiatr Salud Ment"},{"key":"5526_CR6","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/45251","volume":"402","author":"JA Bibb","year":"1999","unstructured":"Bibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, Fienberg AA, Tsai LH, Kwon YT, Girault JA, Czernik AJ, Huganir RL, Hemmings HC Jr, Nairn AC, Greengard P (1999) Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 402:669\u2013671","journal-title":"Nature"},{"key":"5526_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","volume":"25","author":"G Bindea","year":"2009","unstructured":"Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, Fridman WH, Pag\u00e8s F, Trajanoski Z, Galon J (2009) ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25:1091\u20131093","journal-title":"Bioinformatics"},{"key":"5526_CR8","doi-asserted-by":"publisher","first-page":"D723","DOI":"10.1093\/nar\/gkw1040","volume":"45","author":"JA Blake","year":"2017","unstructured":"Blake JA, Eppig JT, Kadin JA, Richardson JE, Smith CL, Bult CJ (2017) the Mouse Genome Database Group,. Mouse Genome Database (MGD)-2017: community knowledge resource for the laboratory mouse. Nucleic Acids Res 45:D723\u2013D729","journal-title":"Nucleic Acids Res"},{"key":"5526_CR9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s00335-011-9385-8","volume":"23","author":"JJ Crowley","year":"2012","unstructured":"Crowley JJ, Kim Y, Szatkiewicz JP, Pratt AL, Quackenbush CR, Adkins DE, van den Oord E, Bogue MA, Yang H, Wang W, Threadgill DW, de Villena FPM, McLeod HL, Sullivan PF (2012) Genome-wide association mapping of loci for antipsychotic-induced extrapyramidal symptoms in mice. Mamm Genome 23:322\u2013335","journal-title":"Mamm Genome"},{"key":"5526_CR10","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.4161\/cc.9.19.13154","volume":"99","author":"M Dalvai","year":"2010","unstructured":"Dalvai M, Schubart K, Besson A, Matthias P (2010) Oct1 is required for mTOR-induced G1 cell cycle arrest via the control of p27(Kip1) expression. Cell Cycle 99:3933\u20133944","journal-title":"Cell Cycle"},{"key":"5526_CR11","doi-asserted-by":"crossref","unstructured":"Divac N, Prostran M, Jakovcevski I, Cerovac N (2014) Second-generation antipsychotics and extrapyramidal adverse effects. Biomed Res Int 656370","DOI":"10.1155\/2014\/656370"},{"key":"5526_CR12","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/ajmg.b.30544","volume":"144B","author":"V Dolzan","year":"2007","unstructured":"Dolzan V, Plesnicar BK, Serreti A, Mandelli L, Zalar B, Koprivsek J et al (2007) Polymorphisms in dopamine receptor DRD1 and DRD2 genes and psychopathological and extrapyramidal symptoms in patients on long-term antipsychotic treatment. Am J Med Genet B Neuropsychiatr Genet 144B:809\u2013815","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"5526_CR13","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/ajmg.b.31245","volume":"156B","author":"A Drago","year":"2011","unstructured":"Drago A, Crisafulli C, Serretti A (2011) The genetics of antipsychotic induced tremors: a genome-wide pathway analysis on the STEP-BD SCP sample. Am J Med Genet B Neuropsychiatr Genet 156B:975\u2013986","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"5526_CR14","doi-asserted-by":"publisher","first-page":"e44853","DOI":"10.1371\/journal.pone.0044853","volume":"7","author":"A Drago","year":"2012","unstructured":"Drago A, Giegling I, Sch\u00e4fer M, Hartmann AM, M\u00f6ller HJ, De Ronchi D et al (2012) No association of a set of candidate genes on haloperidol side effects. PLoS One 7:e44853","journal-title":"PLoS One"},{"key":"5526_CR15","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.euroneuro.2012.08.013","volume":"23","author":"A Drago","year":"2013","unstructured":"Drago A, Giegling I, Sch\u00e4fer M, Hartmann AM, Friedl M, Konte B, M\u00f6ller HJ, de Ronchi D, Stassen HH, Serretti A, Rujescu D (2013) AKAP13, CACNA1, GRIK4 and GRIA1 genetic variations may be associated with haloperidol efficacy during acute treatment. Eur Neuropsychopharmacol 23:887\u2013894","journal-title":"Eur Neuropsychopharmacol"},{"key":"5526_CR16","first-page":"404","volume":"9","author":"P Gass\u00f3","year":"2009","unstructured":"Gass\u00f3 P, Mas S, Bernardo M, Alvarez S, Parellada E, Lafuente A (2009) A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms. Pharm J 9:404\u2013410","journal-title":"Pharm J"},{"key":"5526_CR17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/FPC.0b013e32833efb18","volume":"21","author":"I Giegling","year":"2011","unstructured":"Giegling I, Drago A, Dolzan V, Plesnicar BK, Schafer M, Hartmann AM et al (2011) Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. Pharmacogenet Genomics 21:206\u2013216","journal-title":"Pharmacogenet Genomics"},{"key":"5526_CR18","first-page":"644","volume":"23","author":"JR Gonz\u00e1lez","year":"2007","unstructured":"Gonz\u00e1lez JR, Armengol L, Sol\u00e9 X, Guin\u00f3 E, Mercader JM, Estivill X, Moreno V (2007) SNPassoc: an R package to perform whole genome association studies. Bioinformatics 23:644\u2013645","journal-title":"Bioinformatics"},{"key":"5526_CR19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/FPC.0b013e32800ffbb4","volume":"17","author":"L Greenbaum","year":"2007","unstructured":"Greenbaum L, Strous RD, Kanyas K, Merbl Y, Horowitz A, Karni O, Katz E, Kotler M, Olender T, Deshpande SN, Lancet D, Ben-Asher E, Lerer B (2007) Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication. Pharmacogenet Genomics 17:519\u2013528","journal-title":"Pharmacogenet Genomics"},{"key":"5526_CR20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00213-006-0622-x","volume":"190","author":"A Gunes","year":"2007","unstructured":"Gunes A, Scordo MG, Jaanson P, Dahl ML (2007) Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients. Psychopharmacology (Berlin) 190:479\u2013484","journal-title":"Psychopharmacology (Berlin)"},{"key":"5526_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00228-007-0450-x","volume":"64","author":"A Gunes","year":"2008","unstructured":"Gunes A, Dahl ML, Spina E, Scordo MG (2008) Further evidence for the association between 5-HT2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients. Eur J Clin Pharmacol 64:477\u2013482","journal-title":"Eur J Clin Pharmacol"},{"key":"5526_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00228-006-0234-8","volume":"63","author":"C G\u00fczey","year":"2007","unstructured":"G\u00fczey C, Scordo MG, Spina E, Landsem VM, Spigset O (2007) Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms. Eur J Clin Pharmacol 63:233\u2013241","journal-title":"Eur J Clin Pharmacol"},{"key":"5526_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nature11405","volume":"489","author":"MJ Hawrylycz","year":"2012","unstructured":"Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, Shen EH, Ng L, Miller JA, van de Lagemaat LN, Smith KA, Ebbert A, Riley ZL, Abajian C, Beckmann CF, Bernard A, Bertagnolli D, Boe AF, Cartagena PM, Chakravarty MM, Chapin M, Chong J, Dalley RA, Daly BD, Dang C, Datta S, Dee N, Dolbeare TA, Faber V, Feng D, Fowler DR, Goldy J, Gregor BW, Haradon Z, Haynor DR, Hohmann JG, Horvath S, Howard RE, Jeromin A, Jochim JM, Kinnunen M, Lau C, Lazarz ET, Lee C, Lemon TA, Li L, Li Y, Morris JA, Overly CC, Parker PD, Parry SE, Reding M, Royall JJ, Schulkin J, Sequeira PA, Slaughterbeck CR, Smith SC, Sodt AJ, Sunkin SM, Swanson BE, Vawter MP, Williams D, Wohnoutka P, Zielke HR, Geschwind DH, Hof PR, Smith SM, Koch C, Grant SGN, Jones AR (2012) An anatomically comprehensive atlas of the adult human transcriptome. Nature 489:391\u2013399","journal-title":"Nature"},{"key":"5526_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fnins.2015.00205","volume":"9","author":"I Heinla","year":"2015","unstructured":"Heinla I, Leidmaa E, Kongi K, Pennert A, Innos J, Nurk K et al (2015) Gene expression patterns and environmental enrichment-induced effects in the hippocampi of mice suggest importance of Lsamp in plasticity. Front Neurosci 9:205","journal-title":"Front Neurosci"},{"key":"5526_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.tibs.2009.06.003","volume":"34","author":"J Kang","year":"2009","unstructured":"Kang J, Shakya A, Tantin D (2009) Stem cells, stress, metabolism and cancer: a drama in two Octs. Trends Biochem Sci 34:491\u2013499","journal-title":"Trends Biochem Sci"},{"key":"5526_CR26","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S0006-3223(01)01251-3","volume":"50","author":"S Kapur","year":"2001","unstructured":"Kapur S, Remington G (2001) Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biol Psychiatry 50:873\u2013883","journal-title":"Biol Psychiatry"},{"key":"5526_CR27","doi-asserted-by":"publisher","first-page":"D493","DOI":"10.1093\/nar\/gkh103","volume":"32","author":"D Karolchik","year":"2004","unstructured":"Karolchik D, Hinrichs AS, Furey TS, Roskin KM, Sugnet CW, Haussler D, Kent WJ (2004) The UCSC Table browser data retrieval tool. Nucleic Acids Res 32:D493\u2013D496","journal-title":"Nucleic Acids Res"},{"key":"5526_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.74","volume":"2","author":"K Koido","year":"2012","unstructured":"Koido K, Traks T, Bal\u00f5t\u0161ev R, Eller T, Must A, Koks S, Maron E, T\u00f5ru I, Shlik J, Vasar V, Vasar E (2012) Associations between LSAMP gene polymorphisms and major depressive disorder and panic disorder. Transl Psychiatry 2:e152","journal-title":"Transl Psychiatry"},{"key":"5526_CR29","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.psychres.2014.01.016","volume":"215","author":"K Koido","year":"2014","unstructured":"Koido K, Janno S, Traks T, Parksepp M, Ljubajev \u00dc, Veiksaar P, Must A, Shlik J, Vasar V, Vasar E (2014) Associations between polymorphisms of LSAMP gene and schizophrenia. Psychiatry Res 215:797\u2013798","journal-title":"Psychiatry Res"},{"key":"5526_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.schres.2006.09.031","volume":"90","author":"A Lafuente","year":"2007","unstructured":"Lafuente A, Bernardo M, Mas S, Crescenti A, Aparici M, Gass\u00f3 P et al (2007) Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychotics. Schizophr Res 90:115\u2013122","journal-title":"Schizophr Res"},{"key":"5526_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.psychres.2007.08.002","volume":"161","author":"A Lafuente","year":"2008","unstructured":"Lafuente A, Bernardo M, Mas S, Crescenti A, Aparici M, Gass\u00f3 P et al (2008) Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins\/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders. Psychiatry Res 161:131\u2013141","journal-title":"Psychiatry Res"},{"key":"5526_CR32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9:559","journal-title":"BMC Bioinformatics"},{"key":"5526_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/0269881112463469","volume":"27","author":"BR Lawford","year":"2013","unstructured":"Lawford BR, Barnes M, Swagell CD, Connor JP, Burton SC, Heslop K, Voisey J, Morris CP, Nyst P, Noble EP, Young RM (2013) DRD2\/ANKK1 Taq1A (rs 1800497 C>T) genotypes are associated with susceptibility to second generation antipsychotic-induced akathisia. J Psychopharmacol 27:343\u2013348","journal-title":"J Psychopharmacol"},{"key":"5526_CR34","first-page":"255","volume":"12","author":"S Mas","year":"2012","unstructured":"Mas S, Gass\u00f3 P, Alvarez S, Parellada E, Bernardo M, Lafuente A (2012) Intuitive pharmacogenetics: spontaneous risperidone dosage is related to CYP2D6, CYP3A5 and ABCB1 genotypes. Pharm J 12:255\u2013259","journal-title":"Pharm J"},{"key":"5526_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.euroneuro.2012.04.016","volume":"23","author":"S Mas","year":"2013","unstructured":"Mas S, Gass\u00f3 P, Bernardo M, Lafuente A (2013) Functional analysis of gene expression in risperidone treated cells provide new insights in molecular mechanism and new candidate genes for pharmacogenetic studies. Eur Neuropsychopharmacol 23:329\u2013337","journal-title":"Eur Neuropsychopharmacol"},{"key":"5526_CR36","first-page":"452","volume":"15","author":"S Mas","year":"2015","unstructured":"Mas S, Gass\u00f3 P, Parellada E, Bernardo M, Lafuente A (2015a) Network analysis of gene expression in peripheral blood identifies mTOR and NF-\u03baB pathways involved in antipsychotic-induced extrapyramidal symptoms. Pharm J 15:452\u2013460","journal-title":"Pharm J"},{"key":"5526_CR37","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.2217\/pgs.15.134","volume":"16","author":"S Mas","year":"2015","unstructured":"Mas S, Gass\u00f3 P, Lafuente A (2015b) Applicability of gene expression and systems biology to develop pharmacogenetic predictors; antipsychotic-induced extrapyramidal symptoms as an example. Pharmacogenomics 16:1975\u20131988","journal-title":"Pharmacogenomics"},{"key":"5526_CR38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.euroneuro.2014.11.011","volume":"25","author":"S Mas","year":"2015","unstructured":"Mas S, Gass\u00f3 P, Ritter MA, Malagelada C, Bernardo M, Lafuente A (2015c) Pharmacogenetic predictor of extrapyramidal symptoms induced by antipsychotics: multilocus interaction in the mTOR pathway. Eur Neuropsychopharmacol 25:51\u201359","journal-title":"Eur Neuropsychopharmacol"},{"key":"5526_CR39","first-page":"293","volume":"16","author":"S Mas","year":"2016","unstructured":"Mas S, Gass\u00f3 P, Boloc D, Rodriguez N, M\u00e1rmol F, S\u00e1nchez J, Bernardo M, Lafuente A (2016a) Network analysis of gene expression in mice provides new evidence of involvement of the mTOR pathway in antipsychotic-induced extrapyramidal symptoms. Pharm J 16:293\u2013300","journal-title":"Pharm J"},{"key":"5526_CR40","first-page":"439","volume":"16","author":"S Mas","year":"2016","unstructured":"Mas S, Gass\u00f3 P, Lafuente A, Bioque M, Lobo A, Gonz\u00e0lez-Pinto A et al (2016b) Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes. Pharm J 16:439\u2013445","journal-title":"Pharm J"},{"key":"5526_CR41","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/mp.2009.89","volume":"16","author":"JL McClay","year":"2011","unstructured":"McClay JL, Adkins DE, Aberg K, Stroup S, Perkins DO, Vladimirov VI et al (2011) Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics. Mol Psychiatry 16:76\u201385","journal-title":"Mol Psychiatry"},{"key":"5526_CR42","doi-asserted-by":"publisher","first-page":"W109","DOI":"10.1093\/nar\/gkp402","volume":"37","author":"P Minguez","year":"2009","unstructured":"Minguez P, G\u00f6tz S, Montaner D, Al-Shahrour F, Dopazo J (2009) SNOW, a web-based tool for the statistical analysis of protein-protein interaction networks. Nucleic Acids Res 37:W109\u2013W114","journal-title":"Nucleic Acids Res"},{"key":"5526_CR43","doi-asserted-by":"publisher","first-page":"12840","DOI":"10.1073\/pnas.220410397","volume":"97","author":"A Nishi","year":"2000","unstructured":"Nishi A, Bibb JA, Snyder GL, Higashi H, Nairn AC, Greengard P (2000) Amplification of dopaminergic signaling by a positive feedback loop. Proc Natl Acad Sci U S A 97:12840\u201312845","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"5526_CR44","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1001\/jamapsychiatry.2014.176","volume":"71","author":"JI Nurnberger Jr","year":"2014","unstructured":"Nurnberger JI Jr, Koller DL, Jung J, Edenberg HJ, Foroud T, Guella I (2014) Identification of pathways for bipolar disorder: a meta-analysis. JAMA Psychiatry 71(6):657\u2013664","journal-title":"JAMA Psychiatry"},{"key":"5526_CR45","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.bbagrm.2016.04.003","volume":"1859","author":"A Pance","year":"2016","unstructured":"Pance A (2016) Oct-1, to go or not to go? That is the PolII question. Biochim Biophys Acta 1859:820\u2013824","journal-title":"Biochim Biophys Acta"},{"key":"5526_CR46","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00429-014-0732-x","volume":"220","author":"MA Philips","year":"2015","unstructured":"Philips MA, Lillev\u00e4li K, Heinla I, Luuk H, Hundahl CA, Kongi K, Vanaveski T, Tekko T, Innos J, Vasar E (2015) Lsamp is implicated in the regulation of emotional and social behavior by use of alternative promoters in the brain. Brain Struct Funct 220:1381\u20131393","journal-title":"Brain Struct Funct"},{"key":"5526_CR47","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.celrep.2014.10.015","volume":"9","author":"P Roussos","year":"2014","unstructured":"Roussos P, Mitchell AC, Voloudakis G, Fullard JF, Pothula VM, Tsang J, Stahl EA, Georgakopoulos A, Ruderfer DM, Charney A, Okada Y, Siminovitch KA, Worthington J, Padyukov L, Klareskog L, Gregersen PK, Plenge RM, Raychaudhuri S, Fromer M, Purcell SM, Brennand KJ, Robakis NK, Schadt EE, Akbarian S, Sklar P (2014) A role for noncoding variation in schizophrenia. Cell Rep 9:1417\u20131429","journal-title":"Cell Rep"},{"key":"5526_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003449","volume":"9","author":"AJ Schork","year":"2013","unstructured":"Schork AJ, Thompson WK, Pham P, Torkamani A, Roddey JC, Sullivan PF, Kelsoe JR, O'Donovan MC, Furberg H, The Tobacco and Genetics Consortium, The Bipolar Disorder Psychiatric Genomics Consortium, The Schizophrenia Psychiatric Genomics Consortium, Schork NJ, Andreassen OA, Dale AM (2013) All SNPs are not created equal: genome-wide association studies reveal a consistent pattern of enrichment among functionally annotated SNPs. PLoS Genet 9:e1003449","journal-title":"PLoS Genet"},{"key":"5526_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","volume":"212","author":"GM Simpson","year":"1970","unstructured":"Simpson GM, Angus JW (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212:11\u201319","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"5526_CR50","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/mp.2015.187","volume":"21","author":"M Sokolowski","year":"2016","unstructured":"Sokolowski M, Wasserman J, Wasserman D (2016) Polygenic associations of neurodevelopmental genes in suicide attempt. Mol Psychiatry 21:1381\u20131390","journal-title":"Mol Psychiatry"},{"key":"5526_CR51","doi-asserted-by":"publisher","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","volume":"27","author":"AD Strand","year":"2007","unstructured":"Strand AD, Baquet ZC, Aragaki AK, Holamans P, Yang L, Cleren C et al (2007) Expression profiling of Huntington\u2019s disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration. J Neurosci 27:11758\u201311768","journal-title":"J Neurosci"},{"key":"5526_CR52","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/ajmg.b.30272","volume":"141B","author":"PF Sullivan","year":"2006","unstructured":"Sullivan PF, Fan C, Perou CM (2006) Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 141B:261\u2013268","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"5526_CR53","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"The 1000 Genomes Project Consortium","year":"2015","unstructured":"The 1000 Genomes Project Consortium (2015) A global reference for human genetic variation. Nature 526:68\u201374","journal-title":"Nature"},{"key":"5526_CR54","doi-asserted-by":"crossref","unstructured":"Tybura P, Trze\u015bniowska-Druka\u0142a B, Bienkowski P, Beszlej A, Frydecka D, Mierzejewski P, Samochowiec A, Grzywacz A, Samochowiec J (2014) Pharmacogenetics of adverse events in schizophrenia treatment: comparison study of ziprasidone, olanzapine and perazine. Psychiatry Res 219:261\u2013267","DOI":"10.1016\/j.psychres.2014.05.039"},{"key":"5526_CR55","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fnins.2017.00038","volume":"11","author":"T Vanaveski","year":"2017","unstructured":"Vanaveski T, Singh K, Narvik J, Eskla KL, Visnapuu T, Heinla I et al (2017) Promoter-specific expression and genomic structure of IgLON family genes in mouse. Front Neurosci 11:38","journal-title":"Front Neurosci"},{"key":"5526_CR56","first-page":"34","volume":"68","author":"PJ Weiden","year":"2007","unstructured":"Weiden PJ (2007) Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia. J Clin Psychiatry 68:34\u201339","journal-title":"J Clin Psychiatry"},{"key":"5526_CR57","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1177\/0269881108091594","volume":"23","author":"B Wilffert","year":"2009","unstructured":"Wilffert B, Al Hadithy AF, Sing VJ, Matroos G, Hoeck HW, van Os J et al (2009) The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment: Curacao extrapyramidal syndromes study IX. J Psychopharmacol 23:652\u2013659","journal-title":"J Psychopharmacol"},{"key":"5526_CR58","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10072-016-2808-2","volume":"38","author":"ZH Zhou","year":"2017","unstructured":"Zhou ZH, Wu YF, Wang XM, Han YZ (2017) The c-Abl inhibitor in Parkinson disease. Neurol Sci 38:547\u2013552","journal-title":"Neurol Sci"},{"key":"5526_CR59","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/JCP.0b013e31829abec9","volume":"33","author":"M Zivkovi\u0107","year":"2013","unstructured":"Zivkovi\u0107 M, Mihaljevic-Peles A, Bozina N, Sagud M, Nikolac-Perkovic M, Vuksan-Cusa B et al (2013) The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol. J Clin Psychopharmacol 33:593\u2013599","journal-title":"J Clin Psychopharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05526-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-020-05526-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05526-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T15:07:11Z","timestamp":1650208031000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-020-05526-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,7]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["5526"],"URL":"https:\/\/doi.org\/10.1007\/s00213-020-05526-8","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2020,5,7]]},"assertion":[{"value":"22 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"J. Saiz-Ruiz has been a speaker for and on the advisory boards of Lilly, GlaxoSmithKline, Lundbeck, Janssen, Servier, and Pfizer and has received grant\/honoraria from Lilly and Astra-Zeneca.M. Bernardo has been a consultant for, received grant\/research support and honoraria from, and been on the speakers\/advisory board of ABBiotics, Adamed, Almirall, AMGEN, Boehringer, Eli Lilly, Ferrer, Forum Pharmaceuticals, Gedeon, Hersill, Janssen-Cilag, Lundbeck, Otsuka, Pfizer, Roche, and Servier.The other authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}